European Peptide Drug Summit 2025, where industry leaders meet with peptide innovators to explore cutting-edge technologies and manufacturing know-how shaping the peptide industry.

The healthcare industry is undergoing a technological transformation in peptide therapeutics, requiring enhanced delivery, stability, and bioavailability. Market demands and regulatory standards compel manufacturers to prioritise efficacy and precision targeting in the design and manufacturing of future therapeutics, ensuring safety and robust clinical performance.